🇦🇪United Arab Emirates Active

TATMEEN Emirates Drug Establishment EDE
Serialization Requirements
Level Required Identifier Type Description
Unit Required SGTIN Unit-level serialization with 2D DataMatrix
Case/Bundle Required SSCC Aggregation at case level required
Pallet/Shipper Required SSCC Pallet level aggregation required
Reporting Obligations
Event Type Required Timing Description
Commissioning Required Before distribution Verify and accept serialized goods from supplier
Shipping Required At dispatch Dispatch goods to next GLN
Receiving Required Upon receipt Verify and accept serialized/Aggregated goods from supplier
Aggregation Required Before distribution Repack units into new cartons/pallets
Disaggregation Required On Hierarchy Changing Open carton/pallet and separate child units
Decommissioning Required Inactivate Unit Product Mark damaged, expired, or dispensed packs inactive
Technical Specifications
  • EpcisVersion: 1.2
  • DataFormat: XML
  • IntegrationMethod: API and File Upload
  • BarcodeType: DataMatrix (GS1)
  • RequiredFields: GTIN, Serial Number, Batch/Lot, Expiry Date


Product Scope
  • Convenient Medicines
  • Non-Registered Products
  • Free Medical Sample
Exempt Products
  • OTC Drugs
Official Documents
View All
Manual
Training Manual for File Upload
Tatmeen
Manual
Training Manual for Destruction
Tatmeen
Manual
Training Manual for Product Recall
Tatmeen
Manual
Training Manual for Batch Recall
Tatmeen
Key Deadlines

No deadlines specified

Common Questions
Browse All FAQs

TATMEEN is the UAE's national pharmaceutical track and trace system, operated by the Ministry of Health and Prevention (MoHAP).

It requires manufacturers and importers to serialize products and report EPCIS events throughout the supply chain.

View UAE regulations

Tatmeen is a Ministry of Health and Prevention digital platform that enables the tracking and tracing of all pharmaceutical products in the UAE. It ensures product authenticity and safety throughout the supply chain.

Serialisation is the application of a GS1 approved 2D Matrix barcode and human readable information onto all drug secondary packing. This enables unique identification of each product unit.

Tatmeen became operational on December 13th, 2022, which was 18 months after the decree was issued on June 14, 2021.
Last updated: February 27, 2026